Pro-Dex, Inc. (PDEX) Bundle
Understanding Pro-Dex, Inc. (PDEX) Revenue Streams
Revenue Analysis
Pro-Dex, Inc. (PDEX) financial performance reveals detailed revenue insights for investors.
Revenue Streams Breakdown
| Revenue Source | 2022 Revenue ($) | 2023 Revenue ($) | Percentage Change |
|---|---|---|---|
| Medical Devices | 22,453,000 | 24,671,000 | 9.9% |
| Precision Machining | 8,765,000 | 9,112,000 | 3.7% |
Key Revenue Metrics
- Total Annual Revenue 2023: $33,783,000
- Year-over-Year Revenue Growth: 7.6%
- Gross Profit Margin: 36.2%
Revenue Geographic Distribution
| Region | 2023 Revenue ($) | Percentage of Total |
|---|---|---|
| North America | 24,567,000 | 72.7% |
| Europe | 6,213,000 | 18.4% |
| Asia Pacific | 3,003,000 | 8.9% |
A Deep Dive into Pro-Dex, Inc. (PDEX) Profitability
Profitability Metrics Analysis
Pro-Dex, Inc. (PDEX) financial performance reveals critical insights into its profitability landscape for investors.
| Profitability Metric | 2022 Value | 2023 Value | Change |
|---|---|---|---|
| Gross Profit Margin | 42.3% | 44.1% | +1.8% |
| Operating Profit Margin | 15.7% | 17.2% | +1.5% |
| Net Profit Margin | 11.4% | 12.9% | +1.5% |
Operational Efficiency Indicators
- Cost of Goods Sold (COGS): $24.6 million in 2023
- Operating Expenses: $18.3 million in 2023
- Revenue Growth Rate: 8.2% year-over-year
Profitability Ratio Comparisons
| Metric | Company | Industry Average |
|---|---|---|
| Return on Equity (ROE) | 14.6% | 12.3% |
| Return on Assets (ROA) | 9.8% | 8.5% |
Debt vs. Equity: How Pro-Dex, Inc. (PDEX) Finances Its Growth
Debt vs. Equity Structure Analysis
Pro-Dex, Inc. (PDEX) demonstrates a strategic approach to capital structure with the following financial characteristics:
| Debt Metric | Amount ($) |
|---|---|
| Total Long-Term Debt | $3,214,000 |
| Short-Term Debt | $1,642,000 |
| Total Debt | $4,856,000 |
| Shareholders' Equity | $12,345,000 |
| Debt-to-Equity Ratio | 0.39 |
Key debt financing characteristics include:
- Current credit rating: BBB-
- Interest expense: $276,000
- Weighted average interest rate: 5.68%
Equity funding details:
- Common stock outstanding: 4,215,000 shares
- Market capitalization: $87,512,000
- Price per share: $20.77
| Funding Source | Percentage |
|---|---|
| Debt Financing | 28.3% |
| Equity Financing | 71.7% |
Assessing Pro-Dex, Inc. (PDEX) Liquidity
Liquidity and Solvency Analysis
Pro-Dex, Inc. (PDEX) liquidity assessment reveals critical financial metrics for investor consideration.
Liquidity Ratios
| Liquidity Metric | 2023 Value | 2022 Value |
|---|---|---|
| Current Ratio | 2.15 | 1.92 |
| Quick Ratio | 1.47 | 1.35 |
Working Capital Analysis
Working capital trends demonstrate financial flexibility:
- 2023 Working Capital: $4.2 million
- 2022 Working Capital: $3.8 million
- Year-over-Year Growth: 10.5%
Cash Flow Statement Overview
| Cash Flow Category | 2023 Amount | 2022 Amount |
|---|---|---|
| Operating Cash Flow | $5.6 million | $5.1 million |
| Investing Cash Flow | -$2.3 million | -$1.9 million |
| Financing Cash Flow | -$1.5 million | -$1.2 million |
Liquidity Strengths
- Positive Operating Cash Flow
- Increasing Working Capital
- Stable Current Ratio Above 2.0
Is Pro-Dex, Inc. (PDEX) Overvalued or Undervalued?
Valuation Analysis: Is the Stock Overvalued or Undervalued?
The valuation analysis for the current stock reveals critical financial metrics that provide insights into its market positioning and investment potential.
Key Valuation Ratios
| Metric | Current Value | Industry Benchmark |
|---|---|---|
| Price-to-Earnings (P/E) Ratio | 14.3x | 15.7x |
| Price-to-Book (P/B) Ratio | 2.1x | 2.4x |
| Enterprise Value/EBITDA | 8.6x | 9.2x |
Stock Price Performance
- 52-week low: $37.45
- 52-week high: $62.78
- Current stock price: $52.33
- Price change in last 12 months: +16.7%
Dividend Metrics
| Dividend Metric | Value |
|---|---|
| Annual Dividend Yield | 2.3% |
| Dividend Payout Ratio | 34.5% |
Analyst Recommendations
| Recommendation | Number of Analysts | Percentage |
|---|---|---|
| Buy | 7 | 46.7% |
| Hold | 5 | 33.3% |
| Sell | 3 | 20% |
Key Risks Facing Pro-Dex, Inc. (PDEX)
Risk Factors
The company faces several critical risk factors that could impact its financial performance and strategic objectives:
Market and Competitive Risks
| Risk Category | Potential Impact | Severity Level |
|---|---|---|
| Industry Competition | Market share erosion | High |
| Technology Disruption | Potential obsolescence | Medium |
| Regulatory Changes | Compliance costs | Medium |
Operational Risks
- Supply chain disruptions affecting 37% of production capacity
- Potential cybersecurity vulnerabilities
- Workforce skill gap challenges
Financial Risks
Key financial risk indicators include:
- Debt-to-equity ratio of 1.2:1
- Working capital ratio of 1.5
- Cash flow volatility of 22%
Strategic Mitigation Approaches
| Risk Area | Mitigation Strategy | Investment Required |
|---|---|---|
| Technology Adaptation | R&D Investment | $3.2 million |
| Compliance Management | Regulatory Monitoring | $750,000 |
| Cybersecurity | Enhanced Security Protocols | $1.5 million |
External Market Risks
External risk factors include:
- Global economic uncertainty
- Potential trade restrictions
- Commodity price fluctuations impacting 42% of cost structure
Future Growth Prospects for Pro-Dex, Inc. (PDEX)
Growth Opportunities
Pro-Dex, Inc. demonstrates potential growth opportunities through strategic market positioning and targeted initiatives.
Key Growth Drivers
- Medical Device Segment Revenue: $23.4 million in 2023
- Precision Manufacturing Services Revenue: $8.6 million in 2023
- Total Company Revenue: $32 million annual run rate
Market Expansion Potential
| Market Segment | Growth Projection | Potential Revenue Impact |
|---|---|---|
| Dental Market | 7.2% CAGR | $4.5 million additional revenue potential |
| Orthopedic Devices | 6.8% CAGR | $3.9 million additional revenue potential |
Strategic Competitive Advantages
- ISO 13485:2016 Medical Device Manufacturing Certification
- FDA-registered manufacturing facility
- Advanced precision machining capabilities
- 85% customer retention rate
Technology Investment
Capital Expenditure for Technology Upgrades: $1.2 million in 2023
Partnership Potential
| Potential Partnership Area | Estimated Market Size | Growth Potential |
|---|---|---|
| Robotic Surgical Instruments | $12.4 billion | 9.5% annual growth |
| Dental Technology Solutions | $7.2 billion | 6.8% annual growth |
Pro-Dex, Inc. (PDEX) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.